Henoch-Schonlein Purpura (HSP) Pediatric Research and Clinical Trials

Research & Innovation

Anti-rejection research

Researchers in the Boston Children’s Kidney Transplant Program lead the global development of and participation in pediatric kidney transplant clinical research.

We are committed to developing innovative and improved anti-rejection medication protocols with the goal of more successful transplants and reduced side effects and complications.

As a result of trials managed through our center, certain steroids have been eliminated from post-transplant treatment plans for some children.

National Institutes of Health research programs

We currently participate in more NIH-sponsored pediatric kidney transplant research studies than any other program in the nation.

Additional information about our research is available on our research website, including a list of transplant studies currently enrolling eligible patients.

TransplantResearch Center (TRC)

In 2003, in an effort to speed the knowledge and results gained from research into innovative and improved approaches to the care of transplant patients, Boston Children’s Hospital and Brigham and Woman's Hospital founded the Transplantation Research Center (TRC).

The TRC provides a rich environment for collaboration of scientists and physicians from both institutions in the areas of transplantation and immunology.

The TRC, in conjunction with Children’s Pediatric Transplant Center (PTC)—one of the most advanced and comprehensive transplant centers in the country—reaffirm Children's collaborative "bench-to-bedside" philosophy of care.